Corcept Therapeutics CORT has outperformed the market over the past 5 years by 20.79% on an annualized basis producing an average annual return of 34.33%. Currently, Corcept Therapeutics has a market capitalization of $7.28 billion.
Buying $100 In CORT: If an investor had bought $100 of CORT stock 5 years ago, it would be worth $447.10 today based on a price of $68.63 for CORT at the time of writing.
Corcept Therapeutics's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.